Navigation Links
Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
Date:10/21/2008

"http://www.avidbio.com" target="_new">http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the company will experience delays or difficulties in enrolling patients in the study, the risk that the standard docetaxel response rate will not be improved as a result of the combination therapy, and the risk that the results from this trial will not be consistent with the results of prior trials or preclinical studies. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
7. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Canada (PRWEB) June 17, 2013 As ... to support clinical development, so does the need to ... evolving fit-for-purpose methods. , This webinar, the first in ... approaches to improving biomarker analysis across a range of ... of circulating levels of peptides and proteins than either ...
(Date:6/17/2013)... The Greater Raleigh Chamber of Commerce ... Inc. to its Board of Advisors. "We,re pleased ... of Advisors," said Harvey Schmitt , president and CEO ... positions to hold in the business community. We look forward ... contribute." The Board of Advisors is made up ...
(Date:6/16/2013)... 16, 2013 This training is ideal for ... people outside the software industry or those who want to ... is. , The topics that will be covered in ... roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... , Denver, CO June 28, 2013 , Click here to ...
(Date:6/14/2013)... , June 14, 2013  Royalty Pharma notes today,s ... that it intends to explore a sale of the Company. ... that offers shareholders no certainty that a deal will ever be ... vote today AGAINST all four resolutions up for ... to preserve Royalty Pharma,s formal offer for Elan. In ...
Breaking Biology Technology:Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks 2Raleigh Chamber Names Bob Riedford to Board of Advisors 2Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 2Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 3Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 4Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 5Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 6Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 7Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 8Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 9Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 10Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 11
... Wis. - Wisconsin high-school students are again among ... the ACT , a major college preparedness test. With ... ranked second nationally among states that depend on the ACT, ... , ,While high average scores on the ACT reflect the ...
... and other TV news broadcasts, the accusation that ... board of directors was revealed. Because she was afraid ... chairwoman, Patricia Dunn, unilaterally authorized a project headed up ... on personal phone records of board members. www.msnbc.msn.com/id/14687677/site/newsweek ...
... engine optimization (SEO) tactics have one thing in common: ... and incorporating them into a web site, marketers can ... a desirable search engine ranking requires good information about ... website's industry or topic. A good place to start ...
Cached Biology Technology:Wisconsin students test well on ACT, but relatively few are ready for college rigors 2Wisconsin students test well on ACT, but relatively few are ready for college rigors 3Compliance at HP - Pretexting paranoia 2Compliance at HP - Pretexting paranoia 3Compliance at HP - Pretexting paranoia 4Compliance at HP - Pretexting paranoia 5Search engine optimization: What's the word? 2Search engine optimization: What's the word? 3
(Date:6/13/2013)... Mass. - Qiaobing Xu, assistant professor of biomedical ... named a Pew Scholar in Biomedical Sciences by ... competitive program, whose past winners have included Nobel ... Albert Lasker Basic Medical Research Award, identifies talented ... focuses on nanotechnology for biomedical uses. He will ...
(Date:6/13/2013)... named Pew Latin American Fellows in the Biomedical ... fellowship provides support to advance grantees, research, enables ... invests seed capital to help them establish laboratories ... to postdoctoral researchers investigating some of the world,s ... , "The quest for impactful biomedical discoveries is ...
(Date:6/13/2013)... PHILADELPHIA (June 13, 2013)Twenty-two of the nation,s most ... Biomedical Sciences by The Pew Charitable Trusts today. ... researching the basis of perplexing health problems such ... new scholars join a prestigious community of researchers ... MacArthur fellows, Albert Lasker Basic Medical Research Award ...
Breaking Biology News(10 mins):Tufts Engineer Qiaobing Xu named 2013 Pew Scholar 2On the scientific frontier 2On the scientific frontier 3From autism to diabetes to Parkinson's disease 2From autism to diabetes to Parkinson's disease 3
... a secret that may be the key to defeating it ... Rice University and Baylor College of Medicine (BCM) have found ... evading detection by the immune system. Comparing its genetic ... known appearance in the deadly "Spanish flu" outbreak of 1918, ...
... Newcastle, United Kingdom, December, 2009 Newly published research, ... Institute (NESCI) in the journal Stem Cells ... "Limbal Stem Cell Deficiency" (LSCD) using the patients, own ... LSCD is a painful, blinding ...
... have an influence in making us like sport in ... to a new investigation, physical education teaching staff must ... comparisons between the pupils. The objective is to make ... sport throughout our lives. The objective ...
Cached Biology News:Study reveals H1N1 unexpected weakness 2Successful stem cell therapy for treatment of eye disease 2Physical education teaching staff play key role in making you like sport 2
...
...
Request Info...
... System is ideal for developing single and ... system contains the new, improved, and user ... user can design specific templates for commercial ... fully integrated graphing and data regression capabilities; ...
Biology Products: